Sklero-tablinene en es it fr

Sklero-tablinene Brand names, Sklero-tablinene Analogs

Sklero-tablinene Brand Names Mixture

  • No information avaliable

Sklero-tablinene Chemical_Formula


Sklero-tablinene RX_link

Sklero-tablinene fda sheet

Sklero-tablinene msds (material safety sheet)

Sklero-tablinene MSDS

Sklero-tablinene Synthesis Reference

No information avaliable

Sklero-tablinene Molecular Weight

242.698 g/mol

Sklero-tablinene Melting Point

< 25 oC (boiling point 148-150°C at 25 mm Hg)

Sklero-tablinene H2O Solubility


Sklero-tablinene State


Sklero-tablinene LogP


Sklero-tablinene Dosage Forms

Capsules (orange, oblong, soft-gelatin capsules, each containing 500 mg clofibrate)

Sklero-tablinene Indication

For Primary Dysbetalipoproteinemia (Type III hyperlipidemia) that does not respond adequately to diet.

Sklero-tablinene Pharmacology

Clofibrate is an antilipidemic agent similar to gemfibrozil. It acts to lower elevated serum lipids by reducing the very low-density lipoprotein fraction (Sf 20-400) rich in triglycerides. Serum cholesterol may be decreased, particularly in those patients whose cholesterol elevation is due to the presence of IDL as a result of Type III hyperlipoproteinemia. Several investigators have observed in their studies that clofibrate may produce a decrease in cholesterol linoleate but an increase in palmitoleate and oleate, the latter being considered atherogenic in experimental animals. The significance of this finding is unknown at this time. Reduction of triglycerides in some patients treated with clofibrate or certain of its chemically and clinically similar analogs may be associated with an increase in LDL cholesterol. Increase in LDL cholesterol has been observed in patients whose cholesterol is initially normal. Animal studies suggest that clofibrate interrupts cholesterol biosynthesis prior to mevalonate formation.

Sklero-tablinene Absorption

Completely but slowly absorbed from the intestine. Between 95% and 99% of an oral dose of clofibrate is excreted in the urine as free and conjugated clofibric acid; thus, the absorption of clofibrate is virtually complete.

Sklero-tablinene side effects and Toxicity

Oral, mouse: LD50 = 1220 mg/kg; Oral, rabbit: LD50 = 1370 mg/kg; Oral, rat: LD50 = 940 mg/kg. No reported case of overdosage in humans.

Sklero-tablinene Patient Information

Sklero-tablinene Organisms Affected

Humans and other mammals